If a product is good enough they will be able to raise capital. May not be on the terms they may have once gotten but they can still raise money. This seems to be every biotechs excuse for not getting any sort of deal.
- Forums
- ASX - By Stock
- Ann: $6.6 million Placement to advance clinical trial pipeline
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

If a product is good enough they will be able to raise capital....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $15.69K | 3.919M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 21936206 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 24685267 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 21936206 | 0.004 |
38 | 23301940 | 0.003 |
15 | 12300508 | 0.002 |
10 | 59600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 22760116 | 26 |
0.006 | 13828910 | 16 |
0.007 | 5660001 | 5 |
0.008 | 8542434 | 6 |
0.009 | 2767672 | 5 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |